STAT3 and hepatocellular carcinoma: TSLNC8 was able to competitively bind with transketolase and STAT3, regulate the STAT3-Tyr705 and STAT3-Ser727 phosphorylation expression, repressing the IL-6-STAT3 signaling pathway and suppressing HCC progression and metastasis (228).